As of 2025-06-19, the Intrinsic Value of Phibro Animal Health Corp (PAHC) is 49.26 USD. This PAHC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 23.96 USD, the upside of Phibro Animal Health Corp is 105.60%.
The range of the Intrinsic Value is 24.21 - 170.85 USD
Based on its market price of 23.96 USD and our intrinsic valuation, Phibro Animal Health Corp (PAHC) is undervalued by 105.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 24.21 - 170.85 | 49.26 | 105.6% |
| DCF (Growth 10y) | 30.96 - 185.52 | 57.49 | 140.0% |
| DCF (EBITDA 5y) | 17.95 - 26.88 | 24.33 | 1.5% |
| DCF (EBITDA 10y) | 26.36 - 39.05 | 34.50 | 44.0% |
| Fair Value | 3.92 - 3.92 | 3.92 | -83.63% |
| P/E | 7.23 - 23.44 | 12.87 | -46.3% |
| EV/EBITDA | 10.95 - 25.10 | 19.28 | -19.5% |
| EPV | (2.34) - 1.75 | (0.29) | -101.2% |
| DDM - Stable | 8.42 - 29.66 | 19.04 | -20.5% |
| DDM - Multi | 14.45 - 37.77 | 20.70 | -13.6% |
| Market Cap (mil) | 971.10 |
| Beta | 1.03 |
| Outstanding shares (mil) | 40.53 |
| Enterprise Value (mil) | 1,638.15 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.95% |
| Cost of Debt | 4.47% |
| WACC | 6.21% |